T. Renno et al., Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE, MOL CELL NE, 12(6), 1998, pp. 376-389
The cytokine interferon-gamma (IFN gamma) is implicated in the induction of
acute CNS inflammation, but it is less clear what role if any IFN gamma pl
ays in progression to chronic demyelination and neurological deficit. To ad
dress this issue, we have expressed IFN gamma in myelinating oligodendrocyt
es of transgenic mice. MHC I immunostaining and iNOS mRNA were upregulated
in their CNS, but such transgenic mice showed no spontaneous CNS inflammati
on or demyelination, and the incidence, severity, and histopathology of exp
erimental autoimmune encephalomyelitis (EAE) were similar to nontransgenic
controls. In contrast to control mice, which remit from EAE with resolution
of glial reactivity and leukocytic infiltration, transgenics showed chroni
c neurological deficits. While activated microglia/macrophages persisted in
demyelinating lesions for over 100 days, CD4(+) T lymphocytes were no long
er present in CNS. IFN gamma therefore may play a role in chronic demyelina
tion and long-term disability following the induction of demyelinating dise
ase. Because IFN gamma may have neural as well as immune-infiltrating origi
ns, these findings generate a new perspective on its role in the CNS.